Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-08-24, Stock:JNJ, The news for the past five days is as follows:
2021-08-17: NEWS1: Texas Governor Tests Positive; Masks in Chicago: Virus Update.NEWS2: Is JNJ Stock A Buy Or A Sell As Delta Question Plagues Covid Shot?.NEWS3: ’Outside the hospital & inside the emergency department are struggling for staff members’: GMR Chief Medical Officer.NEWS4: If You Invested $1,000 In Johnson & Johnson Stock One Year Ago, Here's How Much You'd Have Now.NEWS5: UPDATE 1-U.S. plans to begin administering COVID-19 booster shots in September - source.
2021-08-18: NEWS1: Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know.NEWS2: Doctor on U.S. COVID-19 Data : 'Our data collection is frankly pathetic'.NEWS3: ‘We can’t rest complacently in the shield that the vaccines alone give us’: Doctor.NEWS4: 'You can contain this virus if you get vaccinated': Northwell Health CEO.NEWS5: Biden, Fauci, CDC director support COVID-19 booster shots.NEWS6: UPDATE 1-U.S. to begin offering COVID-19 vaccine booster shots in September.NEWS7: The White House Just Announced Its Covid Booster Plan. What to Know..NEWS8: 10 Best Healthcare Dividend Stocks to Buy Now.NEWS9: Here's Why Johnson & Johnson's Vaccine Could Overtake Both Pfizer and Moderna.NEWS10: White House Expected to Announce Booster Plan Today as Covid Cases Climb.NEWS11: Is Johnson & Johnson (JNJ) A Great Investment Pick?.
2021-08-19: NEWS1: Johnson & Johnson CEO Alex Gorsky Is Stepping Aside.NEWS2: Johnson & Johnson CEO Gorsky to step down, become executive chairman.NEWS3: J&J says veteran Duato to replace Gorsky as chief executive.NEWS4: Alex Gorsky to Serve as Executive Chairman and Transition Role of Chief Executive Officer of Johnson & Johnson to Joaquin Duato, Effective January 3, 2022.NEWS5: The US could 'take the lead' in vaccine production: NAM CEO.NEWS6: HIV physician details who should be getting COVID-19 booster shots.NEWS7: Europe Faces Backlash For Importing JNJ COVID-19 Shots From South Africa: Reuters.NEWS8: Why annual COVID-19 booster shots might be unlikely.NEWS9: Scammers selling fake COVID-19 vaccination cards online.NEWS10: Johnson & Johnson Touts Rybrevant Label Expansion After Rare Lung Cancer Approval.NEWS11: U.S. data collection on COVID-19 is 'pathetic': Expert.NEWS12: Morning Brief: The pandemic remains a part of the economic story.NEWS13: Coronavirus spread among kids 'is categorically different with Delta,' doctor explains.NEWS14: UPDATE 3-Facing backlash, EU says import of J&J vaccines from South Africa is temporary.NEWS15: US Set to Receive COVID-19 Vaccine Booster Dose Next Month.NEWS16: Who can get a COVID booster shot, and where do you get one? Here’s what we know so far..NEWS17: EU says import of J&J vaccines from South Africa is temporary.NEWS18: The gap is growing between rich and poor nations on the back of COVID: Ian Bremmer.NEWS19: Johnson & Johnson (NYSE:JNJ) Goes Ex-Dividend Soon.NEWS20: U.S. states rush to meet deadline to join $26 billion opioid settlement.
2021-08-20: NEWS1: Covid Confounds the Fed, Raising the Risk of a Policy Error.NEWS2: Similarweb: 'Consumer demand for travel is showing minimal signs of slowdown'.NEWS3: J&J CEO Alex Gorsky To Exit Stage Left, Handing Reins Over To Covid Czar.NEWS4: Doctor to immunocompromised: 'You should be getting your booster shot'.NEWS5: Doctor on U.S. travel amid the pandemic: ‘I wouldn’t be surprised if we see more restrictions’.NEWS6: Patients 'getting sicker' amid Delta variant surge: Doctor.NEWS7: Johnson & Johnson (JNJ) Up 5.1% Since Last Earnings Report: Can It Continue?.NEWS8: Novavax Stock Could Remain a Winner, Despite its ‘Also Ran’ Status.NEWS9: J&J’s New Insider CEO Brings Expertise From Crucial Pharma Post.NEWS10: Johnson & Johnson’s new leadership, OnlyFans to ban sexually explicit content, Topps SPAC Merger collapses.NEWS11: Coronavirus: 'We’re really still too much in the dark,' Yale professor says.NEWS12: J&J's Alex Gorsky To Step Down As CEO, Hands Baton To Joaquin Duato.NEWS13: J&J (JNJ) CEO Alex Gorsky to Resign, Joaquin Duato to Succeed.NEWS14: Pharma Stock Roundup: FDA Nod for MRK, PFE Products & New Use of LLY, GSK Drugs.NEWS15: J&J’s CEO Plans To Step Down. Analysts Expect a Smooth Transition..NEWS16: The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data.NEWS17: Johnson & Johnson taps Duato as new CEO, replacing Gorsky.NEWS18: Stocks Turn Positive As Nasdaq Paces Gains, Volatility Gauge Ticks Higher.NEWS19: Premarket Movers Friday - Foot Locker, Moderna, Ross Stores, Coinbase.NEWS20: Stocks Slide on Growth, Delta Worries; Moderna, Johnson & Johnson in Focus.NEWS21: Deere, Foot Locker and Spotify Rise Premarket.NEWS22: Johnson & Johnson Stock Lower as Alex Gorsky Plans Exit, Joaquin Duato Named CEO.NEWS23: UPDATE 1-J&J seeks nod for COVID-19 vaccine trial in Indian adolescents.NEWS24: China Tumbles, Gazprom Signals Gas Relief, Tesla Robot -  What's Moving Markets.NEWS25: J&J Drops as Gorsky, Who Steered It Through Crises, Steps Aside as CEO.NEWS26: Stock Futures Slide on Growth, Delta Worries; Moderna, Johnson & Johnson in Focus.NEWS27: Tesla and Robots, Applied Materials, J&J, Apple: 5 Things You Must Know.NEWS28: J&J says veteran Duato to replace Gorsky as chief executive.
2021-08-23: NEWS1: Six U.S. states will not join $26 billion opioid settlements with distributors, J&J.NEWS2: Six U.S. states do not join $26 billion opioid settlements with distributors, J&J.NEWS3: Six U.S. states will not join $26 bln opioid settlements with distributors, J&J.NEWS4: FDA's approval of Pfizer vaccine already paving the way for mandates.NEWS5: 15 Best Reopening Stocks to Buy Now.NEWS6: The FDA approval of Pfizer’s COVID-19 vaccine is a ‘critical step forward in vaccine confidence’: Doctor.NEWS7: Pfizer, BioNTech Gain Ahead of FDA’s Full Approval To Covid Shot.

Answer: Decrease